Pfizer signs agreement with Trump Administration to lower U.S. drug prices and boost…
The agreement covers drug pricing parity, patient discounts through TrumpRx.gov, and a $70 billion U.S. investment commitment
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Latest Updates
Lupin receives US FDA approval for Rivaroxaban for oral suspension
Lupin has received approval from the United States Food and Drug Administration (U.S. FDA) for its Abbreviated New Drug…
Innovation has been at the heart of our growth journey
Sekhar Surabhi, CEO & Founder, Caliber Technologies and Director, ISPE India Affiliate, Chair, ISPE Pharma 4.0, Community of…
Saroj G. Warke receives “Women Empowerment Principles Leadership 2025” Award
Saroj G. Warke, Co-founder and IT Director of HiMedia Laboratories has received the prestigious “Women Empowerment Principles…
Inaugural edition of PCG 2025 marks milestone in India’s pharma innovation journey
The inaugural edition of the Peptides & Complex Generics Symposium (PCG 2025), jointly organised by the Mumbai Biocluster and…
CDSCO clarifies regulatory pathway for combi-pack approvals of Lyophilized injections &…
The Central Drugs Standard Control Organization (CDSCO) has issued a clarification concerning the regulatory approval process for…
Novo Nordisk to launch Ozempic in India, sets stage for GLP-1 market expansion
With semaglutide patents set to expire in 2026, Indian drugmakers are preparing to enter the market with generics. This…
Ayush Ministry inaugurates first integrative oncology research and care centre at AIIA Goa
The Ministry of Ayush inaugurated the Integrative Oncology Research and Care Centre (IORCC) at the All India Institute of Ayurveda…
Lupin acquires VISUfarma to strengthen ophthalmology business
Lupin’s wholly owned subsidiary, Nanomi B.V. ('Nanomi'), has signed a definitive agreement for the acquisition of VISUfarma B.V.…
Turning the tariff tight spot into a sweet spot
US President Trump's fresh salvo of 100 per cent tariffs on branded or patented pharmaceutical products not ‘Made in America’…
Pharma tariff bombshell: Navigating challenges, building resilience
Chakravarthi AVPS, International Trade & Business Relations Expert in pharmaceuticals, opines that for India Pharma Inc, the…
Trump imposes 100 per cent tariff on patented drugs; impact on India to be limited
Industry experts weigh in on the latest tariff move. They highlight limited near-term disruption but caution about long-term risks…
Zydus, Pinkathon come together for breast cancer awareness in India
Zydus Pinkathon announces the 10th Mumbai Edition on December 21, 2025 at MMRDA Grounds, BKC, will engage more than 30,000 women…
Vidal Health and SII collaborate on HPV vaccine access
Digital health programme on Vidal Health’s platform will offer an end-to-end, convenient and cashless experience, making HPV…
Merck appoints Kai Beckmann as Chair of Executive Board and CEO
He will succeed Belén Garijo, and take charge from May 1, 2026
Lupin gets tentative US FDA nod for Bictegravir, Emtricitabine, and Tenofovir Alafenamide tablets
They are indicated for the treatment of human immunodeficiency virus infection in adults and pediatric patients weighing at least…
Alembic receives USFDA approval for Paroxetine Extended-Release tablets
Alembic Pharmaceuticals (Alembic) announced that it has received final approval from the US Food & Drug Administration (USFDA)…
Talent, trials, and trust: Three gaps in India’s biotech boom
In one of the sessions at Scale-Up Health, an Eight Roads Ventures initiative, industry experts identified- absence of early-stage…
Mstack launches Chemstack AI to curb supply chain crisis
Mstack, a vertically integrated specialty chemical company has announced the commercial launch of Chemstack AI, the industry's…
Lupin receives tentative approval from US FDA for Biktarvy tablets
Lupin announced that it has received tentative approval from the United States Food and Drug Administration (US FDA) for its…